Personlig profil
Primære forskningsområder
Diabetes complications research with a focus on chronic kidney disease and cardiovascular disease in people with diabetes.
Fingeraftryk
- 1 Lignende profiler
Samarbejde og topforskningsområder i de sidste fem år
Publikation
-
The Impact of Existing Treatment and Endothelin Receptor Antagonism in Chronic Kidney Disease and Diabetes
Wasehuus, V., 2026Publikation: Afhandlinger › PhD-afhandling
-
Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY study
Wasehuus, V., Rotbain Curovic, V., Tofte, N., Lindhardt, M., Currie, G., Delles, C., Frimodt-Møller, M., Mischak, H., von der Leyen, H., Hansen, T. W., Kümler, T., Persson, F., Rossing, P. & PRIORITY study group, jan. 2025, I: Diabetes, Obesity and Metabolism. 27, 1, s. 387-393 7 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney disease
Wasehuus, V., Smeijer, J. D., Ambery, P., Greasley, P. J., Wijkmark, E., Wheeler, D. C., Rossing, P. & Heerspink, H. J. L., aug. 2025, I: Diabetes, Obesity and Metabolism. 27, 8, s. 4311-4319 9 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone on insulin resistance and markers of inflammation
Wasehuus, V., Smeijer, J. D., Sayer, M., Ambery, P., Greasley, P. J., Wijkmark, E., Cigarran, S., Górriz, J. L., Soler, M. J., Rossing, P. & Heerspink, H. J. L., okt. 2025, I: Diabetologia. 68, Suppl 1, s. S266 514.Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review
-
Left ventricular ejection fraction reserve and its association with myocardial perfusion, coronary calcification, and strain in type 2 diabetes without overt cardiovascular disease
Chebli, A., Rasmussen, I. K. B., Skriver-Møller, A.-C., Hasbak, P., Blond, M. B., Wasehuus, V. S., Lassen, M. C. H., Lindhardt, M., Kofoed-Enevoldsen, A., Kielgast, U. L., Zobel, E. H., Holmvang, L., Biering-Sørensen, T., Rossing, P., Ripa, R. S., Kjaer, A. & Hansen, T. W., dec. 2025, I: Cardiovascular Diabetology. 24, 1, 352.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
ASN Kidney Week 2023
Wasehuus, V. S. (Deltager)
1 nov. 2023 → 5 nov. 2023Aktivitet: Deltagelse i eller arrangering af en begivenhed › Organisation af og deltagelse i konference
-
59th EASD Annual Meeting: EASD 2023
Wasehuus, V. S. (Deltager)
2 okt. 2023Aktivitet: Deltagelse i eller arrangering af en begivenhed › Organisation af og deltagelse i konference
-
Effect of Dapagliflozin on circulating biomarkers of extracellular matrix remodeling in type 2 diabetes with albuminuria: A Randomized Clinical Trial
Wasehuus, V. S. (Oplægsholder)
2 okt. 2023Aktivitet: Tale eller præsentation › Foredrag og mundtlige bidrag
-
Diabetic Kidney Disease & Related Complications
Wasehuus, V. S. (Deltager)
1 okt. 2023 → 2 okt. 2023Aktivitet: Deltagelse i eller arrangering af en begivenhed › Organisation af og deltagelse i konference
-
ASN Kidney Week 2022
Wasehuus, V. S. (Deltager)
2 nov. 2022Aktivitet: Deltagelse i eller arrangering af en begivenhed › Organisation af og deltagelse i konference